World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
45149
World Ranking
5767
National Ranking
3100

Overview

David P. Kelsen is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research portfolio is primarily centered around cancer, with a strong focus on pancreatic and hepatic oncology, as well as cancer genomics and diagnostics.

Their recent publications include:

  • Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation, 2020, Journal of Clinical Oncology
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial, 2020, The Lancet Oncology
  • Tumour extracellular vesicles and particles induce liver metabolic dysfunction, 2023, Nature
  • Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection, 2020, Clinical Cancer Research
  • Artificial Intelligence and Early Detection of Pancreatic Cancer, 2021, Pancreas

David P. Kelsen has frequently collaborated with a range of researchers, including:

  • Eileen M. O'Reilly
  • Kenneth H. Yu
  • Marinela Capanu
  • Wungki Park
  • Anna M. Varghese

Their work is often published in prominent venues such as:

  • Journal of Clinical Oncology
  • Cancer Research
  • Nature Communications
  • Clinical Cancer Research
  • Cancer

Their main fields of study are concentrated in:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their research covers a number of subfields, including:

  • Oncology
  • Cancer Research
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Surgery

The topics addressed in their publications focus heavily on:

  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • Gastric Cancer Management and Outcomes
  • Extracellular vesicles in disease
  • Colorectal Cancer Treatments and Studies
  • Cancer Immunotherapy and Biomarkers

Best Publications

  • Comprehensive molecular characterization of gastric adenocarcinoma

    Adam J. Bass;Vesteinn Thorsson;Ilya Shmulevich;Sheila M. Reynolds

  • INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.

    Bruce D. Minsky;Thomas F. Pajak;Robert J. Ginsberg;Thomas M. Pisansky

  • Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

    David P. Kelsen;Robert Ginsberg;Thomas F. Pajak;Daniel G. Sheahan

  • Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

    Ki Young Chung;Jinru Shia;Nancy E. Kemeny;Manish Shah

  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

    Ayuko Hoshino;Ayuko Hoshino;Han Sang Kim;Han Sang Kim;Linda Bojmar;Linda Bojmar;Linda Bojmar;Kofi Ennu Gyan

  • Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting

    Richard J. Gralla;Loretta M. Itri;Sharon E. Pisko;Anna E. Squillante

  • Long-term results of RTOG trial 8911 (USA intergroup 113): A random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

    David P. Kelsen;Katryn A. Winter;Leonard L. Gunderson;Joanne Mortimer

  • Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas.

    Ephraim S. Casper;Mark R. Green;David P. Kelsen;Robert T. Heelan

  • Multicenter Phase II Study of Irinotecan, Cisplatin, and Bevacizumab in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

    Manish A. Shah;Ramesh K. Ramanathan;David H. Ilson;Alissa Levnor

  • Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.

    Richard J. Gralla;Ephraim S. Casper;David P. Kelsen;David W. Braun

  • Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin

    M G Kris;R J Gralla;R A Clark;L B Tyson

  • Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma

    Kazuyuki Kawakami;Jan Brabender;Reginald V. Lord;Susan Groshen

  • FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

    D Kelsen;O T Atiq;L Saltz;D Niedzwiecki

  • Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis

    Y.Y. Janjigian;D. Werner;C. Pauligk;K. Steinmetz

  • Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.

    Bruce D. Minsky;Alfred M. Cohen;Nancy Kemeny;Warren E. Enker

  • Small-Cell Carcinomas of the Gastrointestinal Tract: A Review

    Baruch Brenner;Laura H. Tang;David S. Klimstra;David P. Kelsen

  • Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors

    Leonard Saltz;Bonnie Trochanowski;Marcia Buckley;Bernadette Heffernan

  • Molecular Classification of Gastric Cancer: A New Paradigm

    Manish A Shah;Raya Khanin;Laura H Tang;Yelena Y. Janjigian

  • Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus

    Jaffer A. Ajani;David H. Ilson;Karen Daugherty;Richard Pazdur

  • Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer

    Alison Grann;Bruce D. Minsky;Alfred M. Cohen;Leonard Saltz

Frequent Co-Authors

Eileen M. O’Reilly
Eileen M. O’Reilly Memorial Sloan Kettering Cancer Center
Manish A. Shah
Manish A. Shah Cornell University
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
Laura H. Tang
Laura H. Tang Memorial Sloan Kettering Cancer Center
Gary K. Schwartz
Gary K. Schwartz Memorial Sloan Kettering Cancer Center
Ghassan K. Abou-Alfa
Ghassan K. Abou-Alfa Memorial Sloan Kettering Cancer Center
Manjit S. Bains
Manjit S. Bains Memorial Sloan Kettering Cancer Center
Bruce D. Minsky
Bruce D. Minsky The University of Texas MD Anderson Cancer Center
Nancy E. Kemeny
Nancy E. Kemeny Memorial Sloan Kettering Cancer Center
Daniel G. Coit
Daniel G. Coit Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical degree in the USA opens the door to a wide range of related online degrees and accelerated career pathways. For those looking to advance quickly, the fastest dnp online program options can help students earn a Doctor of Nursing Practice degree in less time compared to traditional routes. These programs are ideal for working professionals aiming to step up into leadership or specialized practice roles.

If you prefer a less intensive route, consider the easiest dnp program online, which provides a flexible and manageable curriculum for nurses balancing work and study. For those seeking entry-level opportunities, the lpn fast track program allows a quicker path to begin a healthcare career as a Licensed Practical Nurse.

Mental health is another in-demand field, and the psych nurse practitioner programs offer accelerated ways to specialize in psychiatric mental health care. With a flexible online format, these programs support students seeking specialized credentials and a rewarding future in healthcare.

Best Scientists Citing David P. Kelsen

Trending Scientists

Recently Published Articles